Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Leukemia Treatment Drugs Market Size Growth Rate by Type (2014-2025) 1.4.2 Gleevec 1.4.3 Sapacitabine 1.4.4 GA101 1.4.5 Vasaroxine 1.4.6 Tosedosat 1.4.7 Revlimid 1.4.8 Bosutinib 1.5 Market by Application 1.5.1 Global Leukemia Treatment Drugs Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Research Institutes 1.5.4 Diagnostic Centers 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Leukemia Treatment Drugs Market Size 2.2 Leukemia Treatment Drugs Growth Trends by Regions 2.2.1 Leukemia Treatment Drugs Market Size by Regions (2014-2025) 2.2.2 Leukemia Treatment Drugs Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Leukemia Treatment Drugs Market Size by Manufacturers 3.1.1 Global Leukemia Treatment Drugs Revenue by Manufacturers (2014-2019) 3.1.2 Global Leukemia Treatment Drugs Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Leukemia Treatment Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Leukemia Treatment Drugs Key Players Head office and Area Served 3.3 Key Players Leukemia Treatment Drugs Product/Solution/Service 3.4 Date of Enter into Leukemia Treatment Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Leukemia Treatment Drugs Market Size by Type (2014-2019) 4.2 Global Leukemia Treatment Drugs Market Size by Application (2014-2019) 5 United States 5.1 United States Leukemia Treatment Drugs Market Size (2014-2019) 5.2 Leukemia Treatment Drugs Key Players in United States 5.3 United States Leukemia Treatment Drugs Market Size by Type 5.4 United States Leukemia Treatment Drugs Market Size by Application 6 Europe 6.1 Europe Leukemia Treatment Drugs Market Size (2014-2019) 6.2 Leukemia Treatment Drugs Key Players in Europe 6.3 Europe Leukemia Treatment Drugs Market Size by Type 6.4 Europe Leukemia Treatment Drugs Market Size by Application 7 China 7.1 China Leukemia Treatment Drugs Market Size (2014-2019) 7.2 Leukemia Treatment Drugs Key Players in China 7.3 China Leukemia Treatment Drugs Market Size by Type 7.4 China Leukemia Treatment Drugs Market Size by Application 8 Japan 8.1 Japan Leukemia Treatment Drugs Market Size (2014-2019) 8.2 Leukemia Treatment Drugs Key Players in Japan 8.3 Japan Leukemia Treatment Drugs Market Size by Type 8.4 Japan Leukemia Treatment Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Leukemia Treatment Drugs Market Size (2014-2019) 9.2 Leukemia Treatment Drugs Key Players in Southeast Asia 9.3 Southeast Asia Leukemia Treatment Drugs Market Size by Type 9.4 Southeast Asia Leukemia Treatment Drugs Market Size by Application 10 India 10.1 India Leukemia Treatment Drugs Market Size (2014-2019) 10.2 Leukemia Treatment Drugs Key Players in India 10.3 India Leukemia Treatment Drugs Market Size by Type 10.4 India Leukemia Treatment Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Leukemia Treatment Drugs Market Size (2014-2019) 11.2 Leukemia Treatment Drugs Key Players in Central & South America 11.3 Central & South America Leukemia Treatment Drugs Market Size by Type 11.4 Central & South America Leukemia Treatment Drugs Market Size by Application 12 International Players Profiles 12.1 GSK 12.1.1 GSK Company Details 12.1.2 Company Description and Business Overview 12.1.3 Leukemia Treatment Drugs Introduction 12.1.4 GSK Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.1.5 GSK Recent Development 12.2 Pfizer 12.2.1 Pfizer Company Details 12.2.2 Company Description and Business Overview 12.2.3 Leukemia Treatment Drugs Introduction 12.2.4 Pfizer Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.2.5 Pfizer Recent Development 12.3 Novartis AG 12.3.1 Novartis AG Company Details 12.3.2 Company Description and Business Overview 12.3.3 Leukemia Treatment Drugs Introduction 12.3.4 Novartis AG Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.3.5 Novartis AG Recent Development 12.4 Roche 12.4.1 Roche Company Details 12.4.2 Company Description and Business Overview 12.4.3 Leukemia Treatment Drugs Introduction 12.4.4 Roche Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.4.5 Roche Recent Development 12.5 Celgene 12.5.1 Celgene Company Details 12.5.2 Company Description and Business Overview 12.5.3 Leukemia Treatment Drugs Introduction 12.5.4 Celgene Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.5.5 Celgene Recent Development 12.6 Biogen 12.6.1 Biogen Company Details 12.6.2 Company Description and Business Overview 12.6.3 Leukemia Treatment Drugs Introduction 12.6.4 Biogen Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.6.5 Biogen Recent Development 12.7 Genzyme Corporation 12.7.1 Genzyme Corporation Company Details 12.7.2 Company Description and Business Overview 12.7.3 Leukemia Treatment Drugs Introduction 12.7.4 Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.7.5 Genzyme Corporation Recent Development 12.8 Eisai C. 12.8.1 Eisai C. Company Details 12.8.2 Company Description and Business Overview 12.8.3 Leukemia Treatment Drugs Introduction 12.8.4 Eisai C. Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.8.5 Eisai C. Recent Development 12.9 Bristol Myers Squibb Company (BMS) 12.9.1 Bristol Myers Squibb Company (BMS) Company Details 12.9.2 Company Description and Business Overview 12.9.3 Leukemia Treatment Drugs Introduction 12.9.4 Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2014-2019) 12.9.5 Bristol Myers Squibb Company (BMS) Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Leukemia Treatment Drugs Key Market Segments Table Key Players Leukemia Treatment Drugs Covered Table Global Leukemia Treatment Drugs Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Leukemia Treatment Drugs Market Size Market Share by Type 2014-2025 Figure Gleevec Figures Table Key Players of Gleevec Figure Sapacitabine Figures Table Key Players of Sapacitabine Figure GA101 Figures Table Key Players of GA101 Figure Vasaroxine Figures Table Key Players of Vasaroxine Figure Tosedosat Figures Table Key Players of Tosedosat Figure Revlimid Figures Table Key Players of Revlimid Figure Bosutinib Figures Table Key Players of Bosutinib Table Global Leukemia Treatment Drugs Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Research Institutes Case Studies Figure Diagnostic Centers Case Studies Figure Others Case Studies Figure Leukemia Treatment Drugs Report Years Considered Table Global Leukemia Treatment Drugs Market Size 2014-2025 (Million US$) Figure Global Leukemia Treatment Drugs Market Size and Growth Rate 2014-2025 (Million US$) Table Global Leukemia Treatment Drugs Market Size by Regions 2014-2025 (Million US$) Table Global Leukemia Treatment Drugs Market Size by Regions 2014-2019 (Million US$) Table Global Leukemia Treatment Drugs Market Share by Regions 2014-2019 Figure Global Leukemia Treatment Drugs Market Share by Regions 2014-2019 Figure Global Leukemia Treatment Drugs Market Share by Regions 2019 Table Market Top Trends Table Global Leukemia Treatment Drugs Revenue by Manufacturers (2014-2019) (Million US$) Table Global Leukemia Treatment Drugs Market Share by Manufacturers (2014-2019) Figure Global Leukemia Treatment Drugs Market Share by Manufacturers in 2018 Table Global Leukemia Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Leukemia Treatment Drugs Product/Solution/Service Table Date of Enter into Leukemia Treatment Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$) Table Global Leukemia Treatment Drugs Market Size Share by Type (2014-2019) Figure Global Leukemia Treatment Drugs Market Size Market Share by Type (2014-2019) Table Global Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table Global Leukemia Treatment Drugs Market Size Share by Application (2014-2019) Figure Global Leukemia Treatment Drugs Market Size Market Share by Application (2014-2019) Figure Global Leukemia Treatment Drugs Revenue Market Share by Application in 2018 Figure United States Leukemia Treatment Drugs Market Size 2014-2019 (Million US$) Table United States Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$) Table United States Key Players Leukemia Treatment Drugs Market Share (2018-2019) Table United States Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$) Table United States Leukemia Treatment Drugs Market Share by Type (2014-2019) Table United States Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table United States Leukemia Treatment Drugs Market Share by Application (2014-2019) Figure Europe Leukemia Treatment Drugs Market Size 2014-2019 (Million US$) Table Europe Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$) Table Europe Key Players Leukemia Treatment Drugs Market Share (2018-2019) Table Europe Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$) Table Europe Leukemia Treatment Drugs Market Share by Type (2014-2019) Table Europe Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table Europe Leukemia Treatment Drugs Market Share by Application (2014-2019) Figure China Leukemia Treatment Drugs Market Size 2014-2019 (Million US$) Table China Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$) Table China Key Players Leukemia Treatment Drugs Market Share (2018-2019) Table China Leukemia Treatment Drugs Market Size by Type (2014-20189) (Million US$) Table China Leukemia Treatment Drugs Market Share by Type (2014-2019) Table China Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table China Leukemia Treatment Drugs Market Share by Application (2014-2019) Figure Japan Leukemia Treatment Drugs Market Size 2014-2019 (Million US$) Table Japan Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$) Table Japan Key Players Leukemia Treatment Drugs Market Share (2018-2019) Table Japan Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$) Table Japan Leukemia Treatment Drugs Market Share by Type (2014-2019) Table Japan Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table Japan Leukemia Treatment Drugs Market Share by Application (2014-2019) Figure Southeast Asia Leukemia Treatment Drugs Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Leukemia Treatment Drugs Market Share (2018-2019) Table Southeast Asia Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Leukemia Treatment Drugs Market Share by Type (2014-2019) Table Southeast Asia Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Leukemia Treatment Drugs Market Share by Application (2014-2019) Figure India Leukemia Treatment Drugs Market Size 2014-2019 (Million US$) Table India Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$) Table India Key Players Leukemia Treatment Drugs Market Share (2018-2019) Table India Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$) Table India Leukemia Treatment Drugs Market Share by Type (2014-2019) Table India Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table India Leukemia Treatment Drugs Market Share by Application (2014-2019) Figure Central & South America Leukemia Treatment Drugs Market Size 2014-2019 (Million US$) Table Central & South America Key Players Leukemia Treatment Drugs Revenue (2018-2019) (Million US$) Table Central & South America Key Players Leukemia Treatment Drugs Market Share (2018-2019) Table Central & South America Leukemia Treatment Drugs Market Size by Type (2014-2019) (Million US$) Table Central & South America Leukemia Treatment Drugs Market Share by Type (2014-2019) Table Central & South America Leukemia Treatment Drugs Market Size by Application (2014-2019) (Million US$) Table Central & South America Leukemia Treatment Drugs Market Share by Application (2014-2019) Table GSK Company Details Table GSK Revenue in Leukemia Treatment Drugs Business (2014-2019) (Million US$) Figure GSK Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table GSK Recent Development Table Pfizer Company Details Table Pfizer Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Pfizer Recent Development Table Novartis AG Company Details Table Novartis AG Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Novartis AG Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Novartis AG Recent Development Table Roche Company Details Table Roche Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Roche Recent Development Table Celgene Company Details Table Celgene Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Celgene Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Celgene Recent Development Table Biogen Company Details Table Biogen Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Biogen Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Biogen Recent Development Table Genzyme Corporation Company Details Table Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Genzyme Corporation Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Genzyme Corporation Recent Development Table Eisai C. Company Details Table Eisai C. Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Eisai C. Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Eisai C. Recent Development Table Bristol Myers Squibb Company (BMS) Company Details Table Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2014-2019)(Million US$) Figure Bristol Myers Squibb Company (BMS) Revenue Growth Rate in Leukemia Treatment Drugs Business (2014-2019) Table Bristol Myers Squibb Company (BMS) Recent Development Table Global Leukemia Treatment Drugs Market Size by Regions (Million US$) 2019-2025 Figure Global Leukemia Treatment Drugs Market Size Share by Regions (2019-2025) Figure Global Leukemia Treatment Drugs Market Size Share by Regions in 2025 Figure United States Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD) Figure Europe Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD) Figure China Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD) Figure Japan Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD) Figure India Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Leukemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD) Table Global Leukemia Treatment Drugs Market Size by Product (2019-2025) (Million US$) Figure Global Leukemia Treatment Drugs Market Size by Product (2019-2025) Figure Global Leukemia Treatment Drugs Market Size by Product in 2025 Table Global Leukemia Treatment Drugs Market Size by Application (2019-2025) (Million US$) Figure Global Leukemia Treatment Drugs Market Size by Application (2019-2025) Figure Global Leukemia Treatment Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GSK Pfizer Novartis AG Roche Celgene Biogen Genzyme Corporation Eisai C. Bristol Myers Squibb Company (BMS)